Company: Amgen Inc.
Ticker: AMGN
Form: 10-K
Filed: 2026-02-13
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was Amgen Inc.'s total assets in fiscal year 2025?
Question Type: value_lookup

Concept: Assets
Answer (Numeric): 90586.0
Answer (Display): $90,586 million
Unit: USD millions

Evidence:
[{"chunk_id": "279", "equivalent_chunk_ids": ["279"], "section": "CONSOLIDATED BALANCE SHEETS", "supports": ["main"], "text": "December 31, 2025 and 2024\n(In millions, except per-share data)\nASSETS\nCurrent assets:\nCash and cash equivalents\n9,129\n11,973\nTrade receivables, net\n9,570\n6,782\nInventories\n6,225\n6,998\nOther current assets\n4,133\n3,277\nTotal current assets\n29,057\n29,030\nProperty, plant and equipment, net\n7,913\n6,543\nIntangible assets, net\n22,276\n27,699\nGoodwill\n18,680\n18,637\nOther noncurrent assets\n12,660\n9,930\nTotal assets\n90,586\n91,839\nLIABILITIES AND STOCKHOLDERS’ EQUITY\nCurrent liabilities:\nAccounts payable\n2,367\n1,908\nAccrued liabilities\n18,523\n17,641\nCurrent portion of long-term debt\n4,599\n3,550\nTotal current liabilities\n25,489\n23,099\nLong-term debt\n50,005\n56,549\nLong-term deferred tax liabilities\n1,366\n1,616\nLong-term tax liabilities\n2,690\n2,349\nOther noncurrent liabilities\n2,378\n2,349\nContingencies and commitments (see Note 20)\nStockholders’ equity:\nCommon stock and additional paid-in capital; $\n0.0001\npar value per share;\n2,750.0\nshares authorized; outstanding—\n538.8\nshares in 2025 and\n536.9\nshares in 2024\n34,023\n33,533\nAccumulated deficit\n25,107\n27,590\nAccumulated other comprehensive loss\nTotal stockholders’ equity\n8,658\n5,877\nTotal liabilities and stockholders’ equity\n90,586\n91,839\nSee accompanying notes.\nF-6\nAMGEN INC."}]

Derivation: